Zhejiang Chinese Medicine University, Hangzhou, China
通讯作者
Yao-Long Chen; Cheng-Ping Wen
来源期刊
Pharmacological Research
ISSN
1043-6618
EISSN
1096-1186
出版日期
2021-10-29
卷号
174
摘要
Severe Coronavirus Disease 2019 (COVID-19) is characterized by numerous complications, complex disease, and high mortality, making its treatment a top priority in the treatment of COVID-19. Integrated traditional Chinese medicine (TCM) and western medicine played an important role in the prevention, treatment, and rehabilitation of COVID-19 during the epidemic. However, currently there are no evidence-based guidelines for the integrated treatment of severe COVID-19 with TCM and western medicine. Therefore, it is important to develop an evidence-based guideline on the treatment of severe COVID-19 with integrated TCM and western medicine, in order to provide clinical guidance and decision basis for healthcare professionals, public health personnel, and scientific researchers involved in the diagnosis, treatment, and care of COVID-19 patients. We developed and completed the guideline by referring to the standardization process of the "WHO handbook for guideline development", the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, and the Reporting Items for Practice Guidelines in Healthcare (RIGHT).
Key Project “Emergency Prevention and Treatment of COVID- 19′′ of the Zhejiang Provincial Natural Science Foundation of China (grant number LEZ20H190001)
